What treatments are recommended for short‑term nasal congestion due to an acute viral cold?

Treatment for Nasal Congestion from Acute Viral Cold

For short-term relief of nasal congestion due to an acute viral cold, use oral decongestants (pseudoephedrine or phenylephrine) or topical nasal decongestants (oxymetazoline or xylometazoline), but limit topical agents to 3 days maximum to avoid rebound congestion. 1

First-Line Treatment Options

Oral Decongestants

• Pseudoephedrine (60 mg every 4-6 hours) or phenylephrine effectively reduce nasal congestion in both allergic and nonallergic rhinitis 1
• These agents work well in combination with antihistamines for additional symptom relief 1
• Pseudoephedrine demonstrates both objective reduction in nasal airway resistance and subjective improvement in congestion scores 2

Important caveats:

• Can cause insomnia, loss of appetite, irritability, and palpitations 1
• Blood pressure elevation is very rare in normotensive patients and only occasional in controlled hypertensives 1
• Monitor blood pressure in hypertensive patients due to interindividual variation 1
• Use with caution in patients with arrhythmias, angina, coronary artery disease, cerebrovascular disease, or hyperthyroidism 1

Topical Nasal Decongestants

• Oxymetazoline or xylometazoline provide superior short-term efficacy compared to intranasal corticosteroids 1
• Appropriate for acute bacterial or viral infections, allergic rhinitis exacerbations, and eustachian tube dysfunction 1

Critical limitation - Rhinitis Medicamentosa:

• Do not use for more than 3 days 1
• Some patients develop rebound congestion (rhinitis medicamentosa) in as little as 3 days, while others may not show evidence until 4-6 weeks 1
• Given this variability, the prudent approach is to warn patients about the 3-day limit 1
• Recent evidence suggests oxymetazoline may be safe up to 7 days without rebound, but guidelines remain conservative 3

Alternative Considerations

First-Generation Antihistamine/Decongestant Combinations

• Older first-generation antihistamine/decongestant (A/D) preparations can effectively reduce cough associated with viral upper respiratory tract infections 4
• However, first-generation antihistamines cause sedation and performance impairment 1
• Second-generation "non-sedating" antihistamines are relatively ineffective for common cold treatment 4

NSAIDs

• Naproxen decreases cough, headache, malaise, and myalgia in viral colds, supporting inflammation's role in pathogenesis 4

What NOT to Use

• Intranasal corticosteroids: While most effective for allergic rhinitis, they are not indicated for acute viral cold congestion 1
• Antibiotics: Have no role in viral rhinosinusitis. Viral infection involves all nasal and sinus mucosal surfaces, and 79% of patients show resolution without antibiotics by days 13-20 4
• Second-generation antihistamines alone: Ineffective for common cold symptoms 4

Safety Profile

Multiple doses of nasal decongestants show no statistical difference in adverse events compared to placebo (125 per 1000 vs 126 per 1000; OR 0.98) 5. The treatment provides a small but statistically significant benefit with a standardized mean difference of 0.49, indicating modest clinical effect 5.

Clinical Algorithm

1. Start with oral pseudoephedrine (60 mg every 4-6 hours) for most patients
2. Add topical decongestant (oxymetazoline) if rapid relief needed, but strictly limit to 3 days
3. Monitor hypertensive patients for blood pressure changes
4. Avoid in patients with cardiovascular disease, arrhythmias, or hyperthyroidism
5. Counsel patients that symptoms typically resolve within 1 week, though cough may persist longer 4